Skip to content
Medical Health Aged Care, National News Current Affairs

DENTISTS CONGRATULATE RETURNED ALBANESE GOVERNMENT

Australian Dental Association 2 mins read

15.05.25

DENTISTS CONGRATULATE RETURNED ALBANESE GOVERNMENT

 

The Australian Dental Association (ADA) congratulates the Albanese Government on its return and looks forward to working constructively to improve the nation’s oral health.

ADA President Dr Chris Sanzaro said the vote was a national endorsement of the government’s commitment to accessible, affordable health for all Australians.

In particular, the ADA seeks constructive engagement with the government on:

  • the development of the National Oral Health Plan,
  • the enhanced delivery of the Child Dental Benefits Schedule and
  • and building on the successful trial* of a Seniors Dental Benefits Schedule.

During the campaign the ADA released data showing the long-term costs to health of poor oral health, including the impact on hospitalisations of older Australians.

It also supported a senior’s dental trial which showed early intervention delivers real benefits to both the public and the national bottom line. 

“With a solid evidence base to build from, I’m optimistic we can have a positive engagement with the new government and other stakeholders to scale these programs,” Dr Sanzaro said.

 To interview ADA President Dr Chris Sanzaro, contact ADA Media Advisor

Jenny Barlass 0497 748 331

 *The Maroubra Pilot Scheme for Seniors, a first of a kind pilot which saw improvements in participants’ oral health, could be the blueprint for other pilots and a government-funded seniors' dental scheme.

It tackled the oral health of 70 Eastern Sydney seniors with a chronic disease and socioeconomic disadvantage, from November 2024 to March 2025, in which dentists provided dental treatment hand-in-hand with bespoke advice designed to improve oral health and reduce the risk from dental disease on the rest of the body.

Academics from the University of Sydney’s Faculty of Medicine and Health evaluated the effects of the dental treatment on their dental and overall health, and found improvements in oral health outcomes, particularly in the management of tooth decay, gum disease, and provision of prosthodontic care.

Participants also commented on the dental health education they received to help them clean and floss more, and see their dentist more often. These improved oral habits will have a beneficial knock-on effect on their chronic health condition. For more information about the pilot, click here.


Contact details:

ADA Media Advisor Jenny Barlass

0497 748 331

Media

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.